Hellenic Exchanges - Athens Stock Exchange S.A. (ATH:EXAE)
6.95
-0.05 (-0.71%)
Aug 1, 2025, 5:15 PM EET
Verve Therapeutics Market Cap
ATH:EXAE has a market cap or net worth of €402.06 million as of August 1, 2025. Its market cap has increased by 42.71% in one year.
Market Cap
402.06M
Enterprise Value
327.34M
Revenue
58.90M
Ranking
n/a
PE Ratio
18.75
Stock Price
$6.95
Market Cap Chart
Since August 24, 2000, ATH:EXAE's market cap has decreased from 766.38M to 402.06M, a decrease of -47.54%. That is a compound annual growth rate of -2.55%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 404.95M | 55.21% |
Dec 31, 2024 | 260.90M | -14.91% |
Dec 29, 2023 | 306.61M | 70.75% |
Dec 30, 2022 | 179.57M | -19.80% |
Dec 31, 2021 | 223.89M | -4.75% |
Dec 31, 2020 | 235.06M | -15.97% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eurobank Ergasias Services and Holdings | 11.81B |
National Bank of Greece | 11.16B |
Piraeus Financial Holdings | 8.46B |
Attica Bank | 1.81B |
Optima bank | 1.60B |
Bank of Greece | 299.96M |
Cairo Mezz | 143.42M |
Interlife General Insurance Company | 89.61M |